Published in Cancer Weekly, November 28th, 2000
HPV is one of the most common sexually-transmitted diseases (STDs) in the world. StressGen also has active Phase II HspE7 studies in women with HPV-related cervical dysplasia and cervical cancer, and plans to initiate a Phase II study in genital warts.
The company previously reported preliminary data from the first patients in its open label Phase II trial in anal dysplasia at two scientific...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.